Evaluation of the COPDnet integrated care model in patients with COPD: The study protocol

International Journal of COPD

Volumn 13, Issue , 2018, Pages 2237-2244

  Koolen, Eleonore H ^a   van der Wees, Philip J ^a   Westert, Gert P ^a   Dekhuijzen, Richard ^a   Heijdra, Yvonne F ^a   van ’t Hul, Alex J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chronic care model; COPD; COPD management; Health status; Integrated care

Indexed keywords

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; EVIDENCE BASED MEDICINE; GENERAL PRACTITIONER; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH STATUS; HOSPITAL PERSONNEL; INTEGRATED HEALTH CARE SYSTEM; NETHERLANDS; PATIENT CARE; PRIMARY HEALTH CARE; PROGRAM FEASIBILITY; PROSPECTIVE STUDY; SECONDARY HEALTH CARE; SEMI STRUCTURED INTERVIEW; ECONOMICS; FEASIBILITY STUDY; HEALTH CARE PLANNING; HUMAN; PROCEDURES;

DELIVERY OF HEALTH CARE, INTEGRATED; EVIDENCE-BASED MEDICINE; FEASIBILITY STUDIES; HEALTH CARE COSTS; HEALTH PLAN IMPLEMENTATION; HEALTH STATUS; HUMANS; NETHERLANDS; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 85058446336     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S153992     Document Type: Article

References (36)

1. The Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017. Available from: http://goldcopd.org/gold-reports-2017/. Accessed March 29, 2018.
2. Agusti A, Calverley PM, Celli B, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010;11:122.
3. Vestbo J, Agusti A, Wouters EF, et al. Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team. Am J Respir Crit Care Med. 2014;189(9): 1022–1030.
4. Wouters EF. Economic analysis of the Confronting COPD survey: an overview of results. Respir Med. 2003;97(Suppl C):S3–S14.
5. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765–773.
6. Porter ME. What is value in health care? N Engl J Med. 2010;363(26): 2477–2481.
7. Boland MR, Tsiachristas A, Kruis AL, Chavannes NH, Rutten-van Molken MP. The health economic impact of disease management programs for COPD: a systematic literature review and meta-analysis. BMC Pulm Med. 2013;13:40.
8. Kruis AL, Smidt N, Assendelft WJ, et al. Integrated disease management interventions for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2013;10:CD009437.
9. Kayyali R, Odeh B, Frerichs I, et al. COPD care delivery pathways in five European Union countries: mapping and health care professionals’ perceptions. Int J Chron Obstruct Pulm Dis. 2016;11:2831–2838.
10. Koolen EH, van der Wees, PJ, Westert GP, Dekhuijzen PNR, Heijdra YF, van ’t Hul AJ. The COPDnet integrated care model. Int J Chron Obstruct Pulmon Dis. 2018;13:2225–2235.
11. Adams SG, Smith PK, Allan PF, Anzueto A, Pugh JA, Cornell JE. Systematic review of the chronic care model in chronic obstructive pulmonary disease prevention and management. Arch Int Med. 2007; 167(6):551–561.
12. Grol R, Grimshaw J. Frombest evidence to best practice: effective implementation of change in patients’ care. Lancet. 2003;362(9391):1225–1230.
13. Long Alliantie Nederland LAN. Zorgstandaard COPD [Care Standard COPD]. 2016. Available from: http://www.longalliantie.nl/zorgstandaard-copd. Accessed March 29, 2018. Dutch.
14. Doorontwikkeling CQ-index Astma en COPD: validatie van een verko-rte vragenlijst voor het meten van de kwaliteit van astma/COPD-zorg vanuit het perspectief van patiënten [Further development CQ-index Asthma and COPD, Validation of a shortened questionnaire for measuring the quality of asthma/COPD care from the perspective of patients]. Available from: https://www.nivel.nl/sites/default/files/bestanden/CQ-index%20Astma%20en%20COPD%202014.pdf. Accessed March 29, 2018. Dutch.
15. Wensing M, van Lieshout J, Jung HP, Hermsen J, Rosemann T. The Patients Assessment Chronic Illness Care (PACIC) questionnaire in The Netherlands: a validation study in rural general practice. BMC Health Serv Res. 2008;8:182.
16. Bonomi AE, Wagner EH, Glasgow RE, VonKorff M. Assessment of chronic illness care (ACIC): a practical tool to measure quality improvement. Health Serv Res. 2002;37(3):791–820.
17. Hibbard JH, Collins PA, Mahoney E, Baker LH. The development and testing of a measure assessing clinician beliefs about patient self-management. Health Expect. 2010;13(1):65–72.
18. Brownson CA, Miller D, Crespo R, et al. A quality improvement tool to assess self-management support in primary care. Jt Comm J Qual Patient Saf. 2007;33(7):408–416.
19. Vanhaecht K, De Witte K, Depreitere R, et al. Development and validation of a care process self-evaluation tool. Health Serv Manag Res. 2007; 20(3):189–202.
20. van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes. 2003;1:13.
21. Hibbard JH, Mahoney ER, Stockard J, Tusler M. Development and testing of a short form of the patient activation measure. Health Serv Res. 2005;40(6 Pt 1):1918–1930.
22. Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res. 2004;39(4 Pt 1): 1005–1026.
23. Peters JB, Daudey L, Heijdra YF, Molema J, Dekhuijzen PN, Vercoulen JH. Development of a battery of instruments for detailed measurement of health status in patients with COPD in routine care: the Nijmegen Clinical Screening Instrument. Qual Life Res. 2009;18(7):901–912.
24. Vercoulen JH. A simple method to enable patient-tailored treatment and to motivate the patient to change behaviour. Chron Respir Dis. 2012;9(4):259–268.
25. Marshall AL, Smith BJ, Bauman AE, Kaur S. Reliability and validity of a brief physical activity assessment for use by family doctors. Br J Sports Med. 2005;39(5):294–297; discussion 294–297.
26. Kaplan RS, Anderson SR. Time-driven activity-based costing. Harv Bus Rev. 2004;82(11):131–138, 150.
27. Kaplan RS, Porter ME. How to solve the cost crisis in health care. Harv Bus Rev. 2011;89(9):46–52, 54, 56–61 passim.
28. Keel G, Savage C, Rafiq M, Mazzocato P. Time-driven activity-based costing in health care: a systematic review of the literature. Health Policy. 2017;121(7):755–763.
29. Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–1288.
30. Saturni S, Bellini F, Braido F, et al. Randomized Controlled Trials and real life studies. Approaches and methodologies: a clinical point of view. Pulm Pharmacol Ther. 2014;27(2):129–138.
31. Porter ME, Larsson S, Lee TH. Standardizing patient outcomes measurement. N Eng J Med. 2016;374(6):504–506.
32. Worth H, Buhl R, Criee CP, Kardos P, Mailander C, Vogelmeier C. The ‘real-life’ COPD patient in Germany: the DACCORD study. Respir Med. 2016;111:64–71.
33. Buhl R, Criee CP, Kardos P, et al. A year in the life of German patients with COPD: the DACCORD observational study. Int J Chron Obstruct Pulmo Dis. 2016;11:1639–1646.
34. Haughney J, Gruffydd-Jones K, Roberts J, Lee AJ, Hardwell A, McGarvey L. The distribution of COPD in UK general practice using the new GOLD classification. Eur Respir J. 2014;43(4):993–1002.
35. Ke X, Marvel J, Yu TC, et al. Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD. Int J Chron Obstruct Pulm Dis. 2016;11:1689–1703.
36. Coleman K, Austin BT, Brach C, Wagner EH. Evidence on the Chronic Care Model in the new millennium. Health Affairs. 2009;28(1):75–85.